CIDRAP

Phase 3 trial finds Moderna mRNA flu vaccine outperforms standard vaccine in older adults

The findings arrive after a swirl of regulatory uncertainty surrounding the trivalent (three-strain) vaccine, mRNA-1010.
Science Daily

Mutations in noncoding DNA become functional in some cancer-driving genes

Despite progress in defining functional elements of noncoding DNA, it is still not fully understood. Researchers, using an experiment that elucidated the function of tens of thousands of noncoding ...
Hosted on MSN

Mount Sinai maps how early COVID-19 vaccine antibodies face viral evolution

Researchers at Mount Sinai have produced high‑resolution structural maps of antibodies generated after initial mRNA COVID‑19 vaccination, revealing why some lose potency against evolving SARS‑CoV‑2 ...
Applied Clinical Trials Online

Phase 3 Trial Finds Moderna’s mRNA-1010 Influenza Vaccine Outperformed Standard-Dose Vaccines in Adults Aged 50 Years and Older

A phase 3 trial evaluating Moderna’s investigational seasonal influenza vaccine, mRNA-1010, found the messenger RNA ...
The American Spectator

RFK Jr. Cancels $500 Million in mRNA Vaccine Development That Has Posed ‘More Risks Than Benefits’

Health Secretary Robert F. Kennedy Jr. announced plans on Tuesday to cancel 22 mRNA vaccine development contracts totaling nearly $500 million. The move follows a “comprehensive review of mRNA-related ...
Ars Technica

RFK Jr. defends $500M cut for mRNA vaccines with pseudoscience gobbledygook

If anyone needed a reminder that US health secretary and fervent anti-vaccine advocate Robert F. Kennedy Jr. has no background in science or medicine, look no further than the video he posted on ...